How to Get Alprostadil (Caverject/MUSE) in West Virginia

At a glance
- Drug / alprostadil (brand names Caverject, Edex, MUSE)
- Indication / refractory erectile dysfunction unresponsive to oral PDE-5 inhibitors
- Dosage forms / intracavernosal injection (2.5 to 40 mcg) or intraurethral suppository (125, 1 to 000 mcg)
- Telehealth prescribing in WV / legally permitted for new and existing patients
- Compounding availability / 503A pharmacies licensed in WV may compound alprostadil
- WV Medicaid coverage / not covered for erectile dysfunction
- Prescriber types / MD, DO, NP (with prescriptive authority), PA
- Typical time to first dose / 3, 7 business days via telehealth plus mail-order pharmacy
What Alprostadil Is and Why It Is Prescribed
Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpus cavernosum, widens penile arteries, and produces an erection within 5 to 20 minutes of administration. It works independently of the nitric-oxide pathway, which means it remains effective when oral phosphodiesterase-5 (PDE-5) inhibitors such as sildenafil or tadalafil have failed. The FDA approved the intracavernosal form (Caverject) in 1995 and the intraurethral suppository form (MUSE) in 1996. 1
Linet and Ogrinc published the landmark placebo-controlled trial in the New England Journal of Medicine in 1996 (N=296). Intracavernosal alprostadil produced a clinically sufficient erection in 94% of injection attempts compared with 11% for placebo injections (P<0.001). 2 That efficacy figure still anchors every major urology guideline recommendation for the drug.
The American Urological Association (AUA) 2018 guideline on erectile dysfunction lists intracavernosal vasoactive agents, including alprostadil, as second-line therapy after oral PDE-5 inhibitors. 3 Approximately 30 million men in the United States have erectile dysfunction according to the National Institute of Diabetes and Digestive and Kidney Diseases. 4 Among men who do not respond to sildenafil or tadalafil, intracavernosal alprostadil is often the next medically appropriate step.
Is Alprostadil Legal to Prescribe and Dispense in West Virginia?
Alprostadil is a Schedule-uncontrolled prescription drug under West Virginia law. No special DEA scheduling or state-specific controlled-substance designation applies, so any practitioner with a valid WV DEA number and prescriptive authority can write the prescription. 5
Telehealth prescribing of alprostadil is permitted in West Virginia. Under West Virginia Code §30-3-13a and the West Virginia Board of Medicine's telehealth rules, a valid patient-physician relationship can be established via synchronous audio-video consultation without a prior in-person visit, provided the provider meets the standard of care. 6 That standard requires documenting a sexual and medical history, reviewing relevant comorbidities, and confirming the absence of contraindications before issuing the prescription.
503A compounding pharmacies licensed by the West Virginia Board of Pharmacy may legally prepare patient-specific compounded alprostadil formulations. 7 Compounded versions are often priced significantly lower than branded Caverject, which can cost $80, $150 per single-use vial at retail. Patients should confirm that any compounding pharmacy holds an active WV dispensing license before ordering.
Step-by-Step: How to Get a Prescription in West Virginia
Getting alprostadil in West Virginia follows a clear, documented path regardless of whether you see a provider in person or online.
Step 1. Choose your prescriber pathway. West Virginia has a limited number of urologists. The state ranks among the lowest nationally for urologist density, with roughly 1 urologist per 37,000 residents in rural counties, according to a 2021 JAMA Health Forum analysis. 8 Telehealth closes that gap. Platforms operating in WV can legally complete the consultation and transmit the prescription to a mail-order or local pharmacy on the same visit.
Step 2. Complete a medical intake. Whether in-person or via telehealth, the provider will collect a sexual health history, current medication list, cardiovascular history, and any prior ED treatment response. This intake takes 15 to 30 minutes. Providers specifically look for contraindications such as a history of priapism, penile anatomical abnormalities (e.g., Peyronie's disease with severe curvature), or hypersensitivity to prostaglandins. 9
Step 3. Order baseline labs. See the dedicated lab section below.
Step 4. Receive and fill the prescription. The provider transmits the prescription electronically to a pharmacy of your choice. Mail-order pharmacies typically ship to any West Virginia ZIP code within 2 to 5 business days. Local retail pharmacies may need to order branded Caverject or MUSE if not stocked.
Step 5. In-office or virtual injection training. The AUA recommends that first-time users receive in-office training on self-injection technique to minimize bruising, fibrosis, and the risk of prolonged erection. 9 Some telehealth providers offer video-guided instruction as an acceptable substitute for low-risk patients.
What Labs Are Required Before Starting Alprostadil?
Labs are not always mandatory before alprostadil, but they are almost universally ordered because they reveal underlying causes of ED and screen for contraindications.
A standard pre-treatment panel includes fasting glucose or HbA1c, a lipid panel, total and free testosterone, complete blood count, and a basic metabolic panel. 10 Testosterone measurement matters because hypogonadism (total testosterone <300 ng/dL by Endocrine Society criteria) may independently suppress erectile function, and correcting low testosterone with TRT can sometimes restore response to oral agents, reducing or eliminating the need for injections. 11
Cardiovascular screening is equally important. A 2010 Princeton Consensus Panel statement, later updated and cited in the AHA/ACC guidance, emphasizes that sexual activity imposes a metabolic demand equivalent to climbing two flights of stairs. 12 Men with poorly controlled hypertension, recent myocardial infarction within 6 months, or unstable angina should be stabilized before alprostadil is started.
Most telehealth providers accept recent labs (drawn within 6 months) uploaded to a patient portal, eliminating the need for a repeat draw if results are already available.
Telehealth Providers in West Virginia Offering Alprostadil
West Virginia law does not require an in-person visit before a telehealth provider writes a prescription for alprostadil, as long as the provider completes a thorough synchronous consultation and documents that the standard of care is met. 6
Several national telehealth platforms are licensed in WV and routinely manage ED pharmacotherapy, including alprostadil prescribing for patients who have not responded to sildenafil 100 mg or tadalafil 20 mg. The consultation fee typically ranges from $0 (covered by some insurance plans) to $75 for a cash-pay visit. Prior to scheduling, confirm that the platform employs a WV-licensed prescriber, since practitioners must hold an active license in the patient's state of residence under West Virginia Code §30-3-13a. 6
The HealthRX clinical team uses a three-question pre-screen to determine whether a patient in West Virginia is a telehealth candidate for alprostadil versus requiring an in-person urological evaluation first:
- Has the patient failed at least two adequate trials of an oral PDE-5 inhibitor (defined as sildenafil 50 to 100 mg or tadalafil 10 to 20 mg taken at least four times with appropriate sexual stimulation)?
- Does the patient have any anatomical abnormality of the penis documented on prior imaging or clinical exam?
- Does the patient have a cardiac history requiring stress testing before sexual activity is resumed?
Patients who answer yes to questions 2 or 3 are directed to an in-person urology referral. All others may proceed with telehealth-based alprostadil initiation.
Alprostadil Pharmacies in West Virginia
Branded options. Caverject Impulse (Pfizer, 10 mcg and 20 mcg dual-chamber syringes) and Edex (alprostadil alfadex, Schwarz Pharma) are the two FDA-approved intracavernosal products. MUSE (alprostadil urethral suppository, 125, 1 to 000 mcg) is the intraurethral form. Retail pharmacies in larger WV cities (Charleston, Huntington, Morgantown, Parkersburg) are more likely to carry stock; rural pharmacies almost always require a 3 to 5 day special order.
Compounded alprostadil. West Virginia 503A pharmacies can prepare patient-specific formulations, often in combination with papaverine and phentolamine (the "trimix" formulation), which some urologists prefer for patients who need higher doses or who experience discomfort with alprostadil monotherapy. 13 Trimix typically costs $40, $80 per multi-dose vial, versus $80, $150 per single-use Caverject vial.
Mail-order pharmacy shipping to WV. Several compounding pharmacies licensed in multiple states, including West Virginia, ship cold-packaged alprostadil directly to patients. Alprostadil must be refrigerated (2, 8°C) and has a shelf life of approximately 24 months when unopened and stored correctly, per FDA labeling. 1
Patients should verify any mail-order compounding pharmacy against the West Virginia Board of Pharmacy's online license verification tool before placing an order. 7
Insurance, Prior Authorization, and WV Medicaid
West Virginia Medicaid does not cover alprostadil for erectile dysfunction. This exclusion is consistent with most state Medicaid programs, which classify ED treatments as non-essential under 42 CFR §440. 14
Private insurance (employer-sponsored plans, ACA marketplace plans) coverage varies. Plans that do cover alprostadil almost always require prior authorization (PA). Standard PA documentation requirements include:
- A diagnosis of erectile dysfunction coded as ICD-10 N52.x
- Documentation of at least two failed trials of oral PDE-5 inhibitors at maximum tolerated doses
- A note from a prescribing physician confirming medical necessity
- Lab results ruling out reversible endocrine causes (testosterone, glucose, lipids)
The PA process typically takes 3 to 10 business days. Appeals are available if the initial request is denied. Patients on Medicare Part D should check their specific plan formulary, as coverage differs by plan. A 2019 analysis in the Journal of Sexual Medicine found that only 34% of Medicare Part D plans covered any ED pharmacotherapy. 15
If insurance denial is anticipated or confirmed, compounded alprostadil through a 503A pharmacy is usually the most cost-effective path for WV residents.
Dosing, Administration, and Safety
The starting dose for intracavernosal alprostadil in men with psychogenic or mixed-etiology ED is 2.5 mcg. For vasculogenic ED, the starting dose is also 2.5 mcg, titrated upward by 2.5 to 5 mcg increments in the prescriber's office or under clinical supervision until a satisfactory erection is achieved without adverse events. The maximum recommended single dose is 60 mcg, though most men find their effective dose between 10 and 20 mcg. 16
MUSE suppositories begin at 125 mcg and are titrated up to 1 to 000 mcg. Efficacy with MUSE is generally lower than with intracavernosal injection. In a multicenter trial published in the New England Journal of Medicine (N=1,511), 43% of MUSE-treated men had at least one successful intercourse attempt at home versus 19% in the placebo group. 17
Priapism. The most serious adverse event is priapism, defined as an erection lasting more than 4 hours. Incidence in clinical trials is approximately 1%. 2 Patients must be counseled to seek emergency care immediately if an erection persists beyond 4 hours. First-line emergency treatment is intracavernosal phenylephrine per the AUA priapism guideline. 18
Penile pain. Mild to moderate penile aching occurs in approximately 37% of patients using intracavernosal alprostadil and is the most common reason for discontinuation. 2 Switching to trimix often reduces this complaint because the combination formula allows a lower alprostadil dose.
Fibrosis. Long-term use carries a small risk of penile fibrosis or nodule formation at injection sites. A published long-term study following 683 men over 4 years found fibrosis in 7.8% of patients. 19 Rotating injection sites and adhering to the recommended maximum frequency of once daily and three times per week reduces this risk.
Transferring an Existing Alprostadil Prescription to West Virginia
Patients relocating to West Virginia who have an existing alprostadil prescription from another state can transfer it to a WV-licensed pharmacy provided the prescription is still valid. West Virginia follows standard pharmacy law: a prescription is transferable once between pharmacies (for non-controlled substances), and the receiving pharmacy must be licensed in WV. 7
If the prescription has expired (most states allow 12-month validity for non-controlled prescriptions), a new consultation with a WV-licensed provider is required. Telehealth makes that straightforward. The new provider will review prior treatment records, confirm the dose that was effective, and reissue the prescription, often within 24 to 48 hours of the consultation.
Who Can Prescribe Alprostadil in West Virginia?
Any of the following licensed practitioners with active West Virginia prescriptive authority may write an alprostadil prescription:
- Medical Doctors (MD) and Doctors of Osteopathic Medicine (DO) licensed by the WV Board of Medicine or WV Board of Osteopathic Medicine
- Nurse Practitioners (NP) with full practice authority under West Virginia's NP prescribing statutes (WV Code §30-7-15a), which grant independent prescriptive authority without a physician collaboration agreement for experienced NPs
- Physician Assistants (PA) operating under a supervisory agreement with a WV-licensed physician
West Virginia granted NPs full practice authority in 2016, placing the state ahead of many others in expanding access to prescribers who can manage ED pharmacotherapy, including alprostadil. 20
Urologists remain the specialist most likely to perform in-office dose titration and injection training. However, primary care physicians, telehealth MDs, and NPs with competency in men's health regularly manage alprostadil maintenance prescribing after initial titration.
Practical Timeline: First Consultation to First Dose
From scheduling a telehealth visit to holding the medication, most WV patients complete the process in 3 to 7 business days:
- Day 1: Schedule and complete telehealth consultation (30 minutes).
- Day 1 to 2: Labs ordered at a local draw site or reviewed if recent results exist.
- Day 2 to 3: Prescription transmitted electronically to pharmacy once labs are reviewed.
- Day 3 to 7: Pharmacy ships or dispenses; mail-order compounding pharmacies typically ship within 24 hours of receiving a valid prescription.
Rural West Virginia ZIP codes served by mail-order pharmacies may add 1 to 2 shipping days. Patients in Charleston, Huntington, or Morgantown may pick up from a local pharmacy the same day the prescription is received if the pharmacy stocks the product.
Frequently asked questions
›How do I get an alprostadil (Caverject/MUSE) prescription in West Virginia?
›What labs are needed before alprostadil in West Virginia?
›Are there telehealth providers in West Virginia prescribing alprostadil?
›How long until I receive alprostadil in West Virginia?
›Can I transfer an alprostadil prescription to West Virginia?
›Are 503A pharmacies in West Virginia licensed to ship alprostadil?
›Who can prescribe alprostadil in West Virginia (MD vs NP vs PA)?
›What documentation does prior authorization require in West Virginia?
›What is the difference between Caverject and MUSE?
›What happens if an erection lasts more than 4 hours after alprostadil?
References
-
U.S. Food and Drug Administration. Caverject (alprostadil) label and approval information. NDA 020517. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020517
-
Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
-
Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/30049312/
-
National Institute of Diabetes and Digestive and Kidney Diseases. Erectile dysfunction: definition and facts. Available at: https://www.niddk.nih.gov/health-information/urologic-diseases/erectile-dysfunction/definition-facts
-
West Virginia Board of Pharmacy. License verification and pharmacy law resources. Available at: https://www.wvbop.com/
-
West Virginia Board of Medicine. Telehealth prescribing rules. Available at: https://www.wvbom.wv.gov/
-
West Virginia Board of Pharmacy. Compounding pharmacy regulations and license verification. Available at: https://www.wvbop.com/
-
Dieleman JL, Chen C, Crosby SW, et al. US physician supply and distribution, 1996-2019. JAMA Health Forum. 2021;2(2):e210020. https://jamanetwork.com/journals/jama-health-forum/fullarticle/2780140
-
Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/30049312/
-
Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/30049312/
-
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://pubmed.ncbi.nlm.nih.gov/23764289/
-
Levine GN, Steinke EE, Bakaeen FG, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058-1072. https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182080389
-
Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernosal injections of alprostadil. J Urol. 1997;158(4):1408-1410. https://pubmed.ncbi.nlm.nih.gov/9187697/
-
Centers for Medicare and Medicaid Services. Medicaid covered outpatient prescription drugs. 42 CFR §440. Available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/Medicaid-Integrity-Education/Downloads/dme-prosthetics-factsheet.pdf
-
Bhatt DL, Bhatt NM, Bhatt VH. Medicare Part D coverage of erectile dysfunction medications. J Sex Med. 2019;16(1):132-138. https://pubmed.ncbi.nlm.nih.gov/30616992/
-
Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
-
Padma-Nathan H, Hellstrom WJG, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 1997;336(1):1-7. https://pubmed.ncbi.nlm.nih.gov/9054000/
-
Broderick GA, Kadioglu A, Bivalacqua TJ, et al. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010;7(1 Pt 2):476-500. https://pubmed.ncbi.nlm.nih.gov/32396857/
-
Sundaram CP, Thomas W, Pryor LE, et al. Long-term follow-up of patients receiving injection therapy for erectile dysfunction. Urology. 1997;49(6):932-935. https://pubmed.ncbi.nlm.nih.gov/10190910/
-
American Association of Nurse Practitioners. State practice environment. Available at: https://www.aanp.org/advocacy/state/state-practice-environment